The association between institution at orchiectomy and outcomes on active surveillance for clinical stage I germ cell tumours

Authors

  • Madhur Nayan
  • Michael A.S. Jewett
  • Lynn Anson-Cartwright
  • Philippe L. Bedard
  • Malcolm Moore
  • Peter Chung
  • Padraig Warde
  • Joan Sweet
  • Martin O'Malley
  • Robert J. Hamilton

DOI:

https://doi.org/10.5489/cuaj.3513

Abstract

Introduction: Institutional experience has been associated with improved outcomes for various malignancies, including testicular cancer. The present study evaluated whether institution at orchiectomy was associated with outcomes on active surveillance (AS) for clinical stage (CS) I germ cell tumours (GCT).

Methods: 815 patients with CSI GCT managed with AS at the Princess Margaret Cancer Centre were identified. Princess Margaret is a tertiary academic institution with a multidisciplinary testicular cancer clinic involving radiation oncologists, medical oncologists, and urologists, and has research experience in testicular cancer care. The association between institution of orchiectomy (Princess Margaret vs. Other) and time to progression on AS was analyzed using multivariable Cox proportional hazards models. Academic vs. non-academic institutions were compared in a sensitivity analysis.

Results: Patients undergoing orchiectomy at Princess Margaret for non-seminoma GCT were significantly less likely to have pure embryonal carcinoma (EC) in orchiectomy pathology (odds ratio [OR] 0.33; p=0.008) and CSIB disease (OR 0.47; p=0.014). Seminoma characteristics did not differ significantly between institution groups. In non-seminoma GCT, median followup was 5.4 years, 27% progressed on AS, and institution of orchiectomy was not associated with time to progression in either univariate (hazard ratio [HR] 0.79; p=0.33) or multivariable analyses (HR 1.01; p=0.97). In seminoma, median followup was 4.7 years, 12% progressed on AS, and institution of orchiectomy was not associated with progression (univariate: HR 0.87; p=0.73; multivariable: HR 0.98; p=0.96). Sensitivity analyses demonstrated similar results.

Conclusions: Among CSI GCT patients managed on AS at a specialized cancer centre, there appears to be no difference in oncologic outcomes based upon the institution where orchiectomy was performed.

Downloads

Download data is not yet available.

Downloads

Published

2016-06-16

How to Cite

Nayan, M., Jewett, M. A., Anson-Cartwright, L., Bedard, P. L., Moore, M., Chung, P., Warde, P., Sweet, J., O’Malley, M., & Hamilton, R. J. (2016). The association between institution at orchiectomy and outcomes on active surveillance for clinical stage I germ cell tumours. Canadian Urological Association Journal, 10(5-6), 204–9. https://doi.org/10.5489/cuaj.3513

Issue

Section

Original Research